Collegium Pharmaceutical Inc (NASDAQ:COLL) has been given an average rating of “Buy” by the six ratings firms that are presently covering the company. One investment analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average twelve-month target price among brokerages that have covered the […]